Explore the words cloud of the Brain Metastases project. It provides you a very rough idea of what is the project "Brain Metastases" about.
The following table provides information about the project.
THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
|Coordinator Country||United Kingdom [UK]|
|Total cost||183˙454 €|
|EC max contribution||183˙454 € (100%)|
1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
|Duration (year-month-day)||from 2015-05-01 to 2018-02-10|
Take a look of project's partnership.
|1||THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD||UK (OXFORD)||coordinator||183˙454.00|
Brain metastases, particularly from breast cancer, are a significant clinical problem. About one fifth of breast cancer patients that develop metastatic disease will experience brain metastases. Survival is extremely poor, with a median survival of approximately three months. One of the main issues with treating brain metastases is the late stage at which the majority of brain metastases are diagnosed and the ineffectiveness of available therapies as a consequence. At this late point, it is often too late for standard therapies to have a meaningful effect on the progression of the tumours.
In recent years, the role of the immune system in the progression of systemic metastases has been described, with circulating monocytes being found to play a significant role. However, little is known about the pathogenesis of metastases within the brain. The brain possesses a very different environment to the rest of the body, with the blood brain barrier (BBB) tightly regulating the movement of nutrients, drugs and cells into the brain. Consequently, the processes that modeluate metastasis progression in other organs, such as lung and liver, may not be reflected within the brain owing to its unique environment. The overall goal of this fellowship, therefore, will be to determine the role of circulating monocytes in the development of brain metastases from breast cancer with the aim of identifying potential therapeutic routes.
We believe that circulating monocytes may play a significant role in the development and progression of brain metastases as a separate, distinct population from the resident macrophage population (microglia) within the brain. We hypothesize that there is significant circulating monocyte infiltration into brain metastases, which is associated with increased BBB breakdown and disease progression. On this basis, we propose that inhibiting these circulating monocytes will significantly reduce both initiation and progression of brain metastasis.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "BRAIN METASTASES" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (email@example.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "BRAIN METASTASES" are provided by the European Opendata Portal: CORDIS opendata.